Xin Li et al. [35] reported that lixisenatide has a beneficial protective effect against multiple aspects of osteoarthritis (OA), including oxidative stress, expression of proinflammatory cytokines, and activation of the NF-κB proinflammatory signaling pathway. This evidence concerns the gene NFKB1 and osteoarthritis.